REQUEST A DEMO
Total
USD $0.00
Search more companies

Shenzhen Weiguang Biological Products Co.,Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences
Full name: Shenzhen Weiguang Biological Products Co.,Ltd Profile Updated: April 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Shenzhen Weiguang Biological Products Co., Ltd (stock code: 002880) is a national high-tech enterprise and the only blood product manufacturing company in Shenzhen. It is a state-owned listed company in the Guangming District. The company was founded in 1985 and is primarily engaged in the research, production, and sales of blood products. Its product range includes 9 varieties and 21 specifications, such as human albumin and intravenous human immunoglobulin. Over the years, the company has received various honors, including "Guangdong Province Independent Innovation Demonstration Enterprise," "Shenzhen Science and Technology Innovation Award," "Shenzhen Top 100 Quality Enterprises," and "Shenzhen Top 100 Brands." With nearly 40 years of development, the company has become a leading blood product enterprise in China, with high plasma comprehensive utilization rate, complete product range, and strong research and development capabilities. The company covers an area of over 50,000 square meters and has built a first-class life science professional park in the core area of Guangming Science City. It has a highly skilled talent team and employs over 800 people. The company has invested 350 million yuan in a blood product workshop with an annual processing capacity of 500 tons of plasma. It also has 9 single plasma collection stations and 3 subsidiaries. Additionally, it has research and development platforms such as the "Guangdong Protein (Peptide) Separation and Purification Engineering Technology Research and Development Center," with ongoing research in various fields including blood products, vaccines, and recombinant proteins. In the future, the company aims to strengthen its core business in blood products, focusing on the requirements of modern enterprise development. It will leverage the Weiguang Life Science Park and the listing platform to become a pioneer in differentiated blood products in China and a rising star in the global platform-based biopharmaceutical industry.

Headquarters
No. 3402, Guangqiao Avenue, Guangming Street, Guangming New District, Shenzhen, Guangdong Province
Shenzhen; Guangdong; Postal Code: 518107

Contact Details: Purchase the Shenzhen Weiguang Biological Products Co.,Ltd report to view the information.

Website: http://www.szwg.com

Basic Information
Total Employees:
Purchase the Shenzhen Weiguang Biological Products Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the Shenzhen Weiguang Biological Products Co.,Ltd report to view the information.
Registered Capital:
Purchase the Shenzhen Weiguang Biological Products Co.,Ltd report to view the information.
Financial Auditors:
Purchase the Shenzhen Weiguang Biological Products Co.,Ltd report to view the information.
Incorporation Date:
April 07, 1986
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
65.25%
Purchase this report to view the information.
7.25%
Purchase this report to view the information.
1.86%
Purchase this report to view the information.
1.47%
Purchase this report to view the information.
0.9%
Subsidiaries
Ankang Weiguang Apheresis Station Co., Ltd
Debao Guangming Plasma Co., Ltd.
Longan Guangming Plasma Co., Ltd.
Company Performance
Financial values in the chart are available after Shenzhen Weiguang Biological Products Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
8.53%
Total operating revenue
8.53%
Operating profit (EBIT)
-3.17%
EBITDA
-6.8%
Net Profit (Loss) for the Period
2.56%
Total assets
14.19%
Total equity
9.37%
Operating Profit Margin (ROS)
-2.96%
Net Profit Margin
-1.2%
Return on Equity (ROE)
-0.14%
Debt to Equity Ratio
-0.28%
Quick Ratio
-0.8%
Cash Ratio
-0.45%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?